CRISPR has incurred nearly $500 million in losses over the past four quarters. It's burning through cash as the result of its ...

CRISPR Therapeutics AG (CRSP) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Discover the Center for Research in Security Prices (CRSP) at the Booth School of Business, including its historical data on ...

According to Benzinga Pro, CRISPR Therapeutics AG's peer group average for short interest as a percentage of float is 14.28%, ...

Analysts project the U.S. diabetes market will surge past $75 billion by 2031, driven by advanced cell therapies and continuous glucose monitoring systems transforming patient care [3]. Regenerative ...

Wall Street forecasters expect the stock market to grind higher in 2026 as earnings grow, the Fed cuts rates, and the US ...

Cathie Wood, chief of Ark Investment Management, is making moves in megacap tech stocks. Last month, Wood added to her ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Late last year, Lucid Group Inc. (NASDAQ: LCID) began ...

Deere is a major exporter of U.S.-made farm machinery. (Patrick T. Fallon/AFP/Getty Images) Deere expects its tariff costs to double to $1.2 billion when it faces a full fiscal year of higher duties.

Fintel reports that on November 26, 2025, Chardan Capital maintained coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a Buy recommendation. Analyst Price Forecast Suggests 49.92% Upside As of ...

(NEXSTAR) – The predictions are in for winter weather – and they are very different depending on where you live. The Climate Prediction Center, a division of the National Oceanic and Atmospheric ...